If esophageal cancer has metastasized to the lungs, the overall prognosis and survival time will be greatly affected. According to relevant data, most of the patients can only survive for about 1 year, but a small number of patients can survive for 5 years or more.
Esophageal cancer is a malignant tumor occurring in the epithelium of the esophagus. Early stage patients do not have obvious symptoms, while middle and late stage patients may have difficulty in swallowing and other symptoms, and need to take surgical treatment as early as possible.
Lung metastasis of esophageal cancer indicates that the malignant tumor has undergone distal metastasis, and the clinical staging may be in stage IV. Some relevant data show that the 5-year survival rate of patients with stage IV esophageal cancer is less than 10%. It means that only 10% of patients with esophageal cancer survive for 5 years after active treatment.
It should be noted that patients with esophageal cancer lung metastasis can be treated with radiation therapy, chemotherapy and immunotherapy to alleviate clinical symptoms, reduce patients’ pain and strive for prolonging patients’ survival time. It is recommended to cooperate with doctor’s treatment with positive attitude.